Category Specific RSS

Categories: News

Medibio commences testing of app to track mental health

Analysing biometric data of an individual between night and day, medtech company Medibio (ASX: MEB) is set to offer solutions to better manage the mental health of users through an app, aiming to monitor stress levels and improve them over time.

The app will be supported by a biometric wearable divide such as a Garmin or Apple Watch, and will draw upon Medibio’s sleep architecture data which has been clinically tested. According to the Company, there is no other viable app in the current marketplace that has patent-protected biometric functionality.

While mental health has been an emerging trend within the health and wellness sector, the COVID-19 pandemic has shone a spotlight on personal management where some have not handled pandemic lockdowns as well as others.

In the United States, where Medibio has an office in Minneapolis, a Kaiser Family Foundation study identified the pandemic to have negatively affected the mental health of 53% adult Americans. Critical responses identified in the study included sleeping difficulty, changes to eating patterns and increases in alcohol or substance abuse as common reactions within the population due to stress over the virus.

With the increasing demand for mobile mental health services, Medibio is planning to make their app available on Android and iOS platforms. It is yet to be discussed how Medibio will generate revenue from the app, or partnerships with wearable device companies but they are planning to also include functionality for those who do not have wearables via an interactive psychometric assessment feature.

Pending testing of their app, Medibio has tentatively scheduled a commercial launch in advance of Mental Health Awareness Week in October 2021 and is not expecting to require FDA approval for it.

Depression is estimated to cost the US economy USD $210 billion a year while the cost in Australia is estimated at $12.6 billion annually.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

4 days ago

DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment

DroneShield (ASX:DRO) is expanding its Australian footprint with a $13 million investment to establish a…

2 weeks ago

Stakk Secures T-Mobile Contract to Power Super App Expansion

Australian fintech Stakk (ASX:SKK) has signed a three-year agreement with U.S. telecommunications giant T-Mobile USA,…

3 weeks ago

Medibank Backs Emyria with Landmark Depression Care Deal

Australia’s mental health burden is growing – and one of the toughest challenges is treatment-resistant…

4 weeks ago

NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI

NoviqTech Limited (ASX:NVQ) has taken a decisive step into the quantum computing market, unveiling the…

1 month ago

BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil

Brazilian Rare Earths Limited (ASX:BRE) has cleared its last regulatory hurdle to begin pilot operations…

2 months ago